Biosimilars News

EMA approved 104 human medicines in 2025: what changed

EMA · osteoporosis · 6 min

Eye drugs list: Sodium hyaluronate, tafluprost, tobramycin uses

FDA · dry eyes · 5 min

Biosimilar Approvals: U.S. vs. Europe Insights for Pharma BD

FDA · 6 min

EMA Approves New Medicines in January: Key Updates for Pharma Investors and BD Teams

EMA · 7 min

European Commission Approves POHERDY, First Pertuzumab Biosimilar in Europe by Henlius and Organon

2 min

Henlius and Organon's POHERDY Becomes First Pertuzumab Biosimilar Approved in Europe

2 min

Biocon Receives Health Canada Approval for Denosumab Biosimilars Bosaya and Vevzuo

2 min

Cigna Healthcare Adds Accord BioPharma's IMULDOSA Biosimilar to Preferred Coverage Plans

2 min

EMA Biosimilar Policy: Market Impact and Regulatory Insights 2024

EMA · autoimmune diseases · 4 min

Denosumab Biosimilar Authorization by EMA: Key Details

EMA · osteoporosis · 4 min